NewsSource: EClinCloud

EClinCloud Product Overview | CTMS · Clinical Trial Management System

2 min readEClinCloud Editorial Team
News thumbnail for EClinCloud Product Overview | CTMS · Clinical Trial Management System

Source: EClinCloud. Author: EClinCloud.


EClinCloud CTMS (Clinical Trial Management System) is a project-management-centered system spanning the entire clinical trial lifecycle, primarily used to manage projects, timelines, participants, quality, and costs across all stages of a clinical trial. Through EClinCloud CTMS, investigators can track and monitor trial projects online in real time, effectively reducing clinical trial management costs and improving clinical trial management quality and efficiency.


computer-ai.png

AI-Driven One-Stop Product + Service Solution


🔍What Does EClinCloud Offer?

◉ CTMS System

◉ 1-on-1 Role-Based Hands-On Training

◉ Open APIs

◉ ECC ONE Mobile



💻EClinCloud CTMS Features




◉ Lightly customized system solution to build a dedicated clinical trial management platform

◉ Dynamic visual dashboards consolidating key project metrics so investigators can quickly understand project status

◉ AI-enabled end-to-end clinical trial project management to reduce frontline and administrative workload

◉ Ecosystem integration with CTMS as the unified platform hub, connecting with EDC and eTMF for data synchronization



💡Why Choose EClinCloud CTMS?


❖ Enables granular management across the entire clinical trial lifecycle to drive significant gains in trial efficiency

❖ Collaborates with users to build an RBQM ecosystem and establish a complete closed-loop risk and quality control workflow

❖ Offers managed CTMS services to free teams from routine system administration tasks

❖ Delivers responsive support to build collaborative, mutually beneficial partnerships with users






About EClinCloud


EClinCloud is a leading AI company in the clinical research industry. Powered by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products—including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM—as well as scale management, linguistic validation, rater training, and data quality analysis services. By delivering efficient, precise digital solutions and leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically evaluates and helps improve drug clinical trial success rates, helping shorten drug and medical device R&D cycles to benefit patients.  







Article illustration





Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.